Skip to main content

Table 4 Alleles’ frequencies in the studied group

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

SNPs Alleles carrier Frequency % (N)
ERCC1 118 C/T C allele 54.55 (48)
T allele 45.45 (40)
ERCC1 8092 C/A C allele 62.5 (55)
A allele 37.5 (33)
ERCC2 312 G/A G allele 67.05 (59)
A allele 32.95 (29)
ERCC2 751 A/C A allele 70.7 (58)
C allele 29.3 (24)